Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 20, 2007Company to host analyst meeting and symposium on drug-eluting stents
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the annual...
-
Mar 13, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lehman Brothers Health Care Conference, which is being held March 19...
-
Mar 12, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that its Board of Directors has authorized management to explore an initial public...
-
Mar 8, 2007
Boston Scientific Corporation (NYSE: BSX) today announced several enhancements related to the governance of the company. "Boston Scientific is...
-
Mar 6, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Cowen Health Care Conference, which is being held March 12 - 15 in...
-
Mar 5, 2007
Boston Scientific Corporation (NYSE: BSX) released the following statement today in response to a request for information relating to its TAXUS®...
-
Feb 28, 2007Campaign spokesperson - a Formula race car driver, amputee, and chronic pain patient - to promote public awareness
Boston Scientific Corporation (NYSE: BSX) announced today the launch of its Neuromodulation Group's Race Against Pain public outreach campaign to...
-
Feb 12, 2007
Boston Scientific Corporation (NYSE: BSX) today commented on results from a Swedish registry assessing the long-term outcomes of drug-eluting...
-
Feb 12, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed the online release of several important articles scheduled for publication in the March...
-
Feb 5, 2007DES patients have significantly lower rates of death, heart attack and re-intervention than BMS patients
Boston Scientific Corporation (NYSE: BSX) today welcomed data from a study showing that drug- eluting stents (DES) have substantially lower rates of...